Stockscreener 앱 받기
0.77
1.71%
-0.0134
시간 외 거래:
.76
-0.01
-1.30%
Calidi Biotherapeutics Inc 주식(CLDI)의 최신 뉴스
Enterprise value to EBITDA forward of Calidi Biotherapeutics Inc. – OTC:CLDWW - TradingView
Calidi Biotherapeutics (NYSEAMERICAN:CLDI) Races to Fix an Equity Shortfall Before Delisting - kalkine.ca
Calidi Biotherapeutics Addresses NYSE American Compliance Notice - The Globe and Mail
Calidi Biotherapeutics Received Notice of Noncompliance - TradingView
Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency - GlobeNewswire Inc.
Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency - GlobeNewswire
Calidi Biotherapeutics Announces Registered Direct Stock Offering - The Globe and Mail
Calidi Biotherapeutics Finalizes $1.2M Registered Direct Stock Offering - Kalkine Media
Calidi Biotherapeutics Raises $1.2 Million in Registered Direct Offering at $1.17 Per Share - tradingview.com
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering - Quiver Quantitative
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering - GlobeNewswire
A biotech plans to raise about $1.2 million by selling shares at $1.17 each. - Stock Titan
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering - Yahoo Finance
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
CLDI Q4 2025 Earnings: Loss Narrows Sharply, Beating Estimates by 73.59%; Shares Rise 3.41%Dividend Earnings Report - vinanet.vn
ARMISTICE CAPITAL, LLC Slashes Calidi Biotherapeutics (CLDI) Sta - GuruFocus
Calidi (CLDI) Quarterly Scorecard: EPS Exceeds Its Estimate in Latest Trading; Market Response: Shares Move Lower 2.90%Dividend Cut Risk - vinanet.vn
Calidi Biotherapeutics (CLDI) grants director 5,000 options - Stock Titan
Calidi director granted 4,000 options at $1.36 | CLDI Insider Trading - Stock Titan
Calidi Biotherapeutics (CLDI) gives CFO 14,000 options with 10-year term - Stock Titan
Calidi Biotherapeutics (CLDI) awards director 4,000 options vesting in 1 year - Stock Titan
Calidi Biotherapeutics (CLDI) CEO awarded 32K options vesting over 4 years - Stock Titan
Calidi Biotherapeutics (CLDI) awards 16,000 options to CSO - Stock Titan
Calidi (CLDI) Report Card: The EPS Result Is Above Expectation in the Current Update; Reaction Snapshot: Shares Close 6.62% Lower in the Latest SessionTrough Earnings Signal - vinanet.vn
Calidi (CLDI) Closing Snapshot: Retreats 5.59% to $1.28 in the Current Update; Technical Position: the Near-Term Reference Band Stretches From $1.22 to $1.34 on the DayCalendar Spread Trade - vinanet.vn
Calidi Biotherapeutics Granted Patent for Cell-Based Oncolytic Virus Immunotherapy for Cancer Treatment - ACCESS Newswire
Armistice Capital reports 4.99% Calidi Biotherapeutics (CLDI) stake in Schedule 13G/A - Stock Titan
Form 8K Calidi Biotherapeutics Inc For: 13 August By Investing.com - Investing.com Nigeria
Calidi Biotherapeutics Reports Quarterly Results and Pipeline Progress - TipRanks
Calidi Biotherapeutics Q2 net loss narrows to $4.2M; G&A cuts 48% - scanx.trade
Calidi Biotherapeutics 2Q 2026: Net loss $4.16M, EPS $(2.94) — 10-Q Summary - TradingView
Form 8K Calidi Biotherapeutics Inc For: 13 August By Investing.com - Investing.com Canada
Form 8K Calidi Biotherapeutics Inc For: 13 August By Investing.com - Investing.com India
Calidi Biotherapeutics Reports Positive FDA Pre-IND Feedback for CLD-401, Showcases RedTail Platform Data and Cuts G&A Expenses - Quiver Quantitative
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights - Yahoo Finance
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewswire
Price to book forward of Calidi Biotherapeutics Inc. – OTC:CLDWW - TradingView
Price to sales forward of Calidi Biotherapeutics Inc. – OTC:CLDWW - TradingView
Calidi Biotherapeutics (CLDI) Holds Steady at $1.63 as Stock Sits Between Support and ResistanceEntry Point Alerts - dars.gov.et
CLDI Q4 2025 Earnings: Narrower Loss of -$0.43 Per Share Beats Estimates, Stock Falls 9.5%High Estimate Range - vinanet.vn
Calidi Biotherapeutics (CLDI) Insider Trading Activity 2026 $CLDI - MarketBeat
Calidi Biotherapeutics Inc (CLDI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Calidi Biotherapeutics (CLDI) Falls 6.88% to $1.76, Pressing Key Support at $1.67Straddle Setup - vinanet.vn
Calidi Biotherapeutics (CLDI) Jumps 12.5% to $1.89 as Bullish Momentum Builds Toward $1.98 ResistanceSector Neutral Pair - vinanet.vn
Price to sales forward of Calidi Biotherapeutics, Inc. – BOATS:CLDI - TradingView
Calidi Biotherapeutics Inc. (NYSE: CLDI) Share Price, CLDI Stock News, CLDI Share Price & Updates - Kalkine
Calidi Biotherapeutics (CLDI) Surges 9.86% to $1.64 as Buying Pressure BuildsGolden Cross - vinanet.vn
Calidi Biotherapeutics (CLDI) Surges 9.86% to $1.64 as Buying Pressure BuildsValue Stock Ideas - careplusvn.com
Calidi Biotherapeutics Announces Reverse Stock Split to Maintain NYSE American Listing – July 2026 8-K Filing - Minichart
1.08%
2.09%
자본화:
|
볼륨(24시간):